
    
      The first component of this study will be a longitudinal, prospective, 24 weeks study of the
      effects of HIV-1 infection on innate and acquired immunity in the lung (Cohort A). The second
      component of this study will be a cross-sectional, case-control study of lung function and
      immune dysregulation of HIV-1 infected persons on long-term ART (Cohort B).

      Cohort A will consist of 120 subjects, stratified by HIV-1 and smoking status

      Cohort B will consist of 90 subjects stratified by chronic obstructive pulmonary disease
      (COPD) and HIV-1 infection.
    
  